Delivery Order SPE2DB24D1205-SPE2DB25FDAFN
- Not listed
- The Defense Logistics Agency (DLA) awarded a $11,830.00 delivery order to AmerisourceBergen Drug Corp for SKYRIZI 150 MG/ML pen/milliliter pharmaceutical product on September 4, 2025, with completion expected by September 5, 2025. This is a firm fixed-price contract with no set-aside designation, competitively awarded to the prime contractor. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of SKYRIZI 150 mg/mL in pen form, valued at $24,893.20 under a firm fixed-price contract awarded on August 24, 2025. This delivery order represents a child contract under AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.99 billion master contract running through December 2026 that serves as a comprehensive global pharmaceutical...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a $11,972.91 delivery order on August 19, 2025, for SKYRIZI 150 MG/ML pen/mL, a prescription biologic medication. This firm fixed price, competitively awarded contract is a child order under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026. The place of performance is AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a $12,962.95 delivery order to AmerisourceBergen Drug Corp on July 25, 2025, for the supply of SKYRIZI 150 mg/ml pen injections. This is a firm fixed-price contract with an ultimate completion date of July 28, 2025, and was competitively awarded with no set-aside designation. The contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, a comprehensive $999,999,999.00...
- The Defense Logistics Agency awarded a $17,574.35 delivery order to AmerisourceBergen Drug Corp for SKYRIZI 150 mg/ml pen vials under a firm fixed price contract type. This competitive award, issued on August 11, 2025, with an ultimate completion date of August 12, 2025, represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The delivery location is specified as Conshohocken, Pennsylvania, the company's corporate...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 18, 2025, for the supply of SKYRIZI 150 MG/ML PenML, a pharmaceutical product, with a ceiling value of $26,166.64. This competitively awarded, firm fixed-price delivery order is set to conclude on August 19, 2025, and will be fulfilled from the vendor's facility in Conshohocken, Pennsylvania. The contract represents a continuation of AmerisourceBergen's role as a critical...
- The Defense Logistics Agency awarded a $14,917.68 delivery order (Contract No. 4569133354) to AmerisourceBergen Drug Corp on August 18, 2025, for the supply of SKYRIZI 150 mg/ml pen injectors. The award represents a firm fixed price delivery order with no set-aside designation, indicating competitive procurement. Performance is scheduled to be completed by August 19, 2025, with fulfillment occurring at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery...
- The Defense Logistics Agency awarded a delivery order valued at $14,794.36 to AmerisourceBergen Drug Corp for the supply of SKYRIZI 150 mg/ml syringes. This is a firm fixed-price, competitively awarded contract with no set-aside designation, featuring an ultimate completion date of July 31, 2025. The contract was executed on July 30, 2025, with performance taking place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a $11,830 delivery order to AmerisourceBergen Drug Corp on August 20, 2025, for the supply of SKYRIZI 360 mg/2.4 ml on-body applicator units. The contract is firm fixed price with no set-aside designation and carries an ultimate completion date of September 11, 2025. Performance will be executed from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a $41,824.89 delivery order to AmerisourceBergen Drug Corp for SKYRIZI 150 mg/ml pen medication on September 2, 2025, with completion expected by September 3, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a child contract action under a larger procurement vehicle. This delivery order...
- SPE2DB24D1205Indefinite Delivery Contract
- SPE2DB24D1205-SPE2DB25FDAFNDelivery Order
The Defense Logistics Agency awarded a $279,751.97 delivery order to AmerisourceBergen Drug Corp on September 8, 2025, for the supply of SKYRIZI 150 MG/ML in pen/milliliter formulation. This is a firm fixed price contract with no set-aside designation, executed as a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The contract is set to be completed by September 9, 2025, with fulfillment occurring at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, holds a comprehensive $999,999,999.00 IDC (SPE2DX) with DLA Troop Support Medical through December 2026, which serves as the prime vehicle enabling delivery of pharmaceuticals and medical supplies to military healthcare programs globally. This delivery order for SKYRIZI—a biologic medication used in dermatological and immunological treatments—represents one of numerous competitively awarded transactions through this vehicle, demonstrating AmerisourceBergen's established capability to meet federal medical procurement requirements across diverse therapeutic domains and customer bases including the Defense Health Agency and U.S. Coast Guard.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $279.8k | 9/8/25 |